Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer

PURPOSE: Treatment options for refractory metastatic colorectal cancer (CRC) are scarce. This retrospective study aimed to evaluate the efficacy and safety of raltitrexed combined with S-1 and bevacizumab in patients with heavily pretreated metastatic CRC in a clinical real-world setting. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiu, Ma, Xiaoting, Ou, Kai, Wang, Qi, Gao, Lizhen, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038009/
https://www.ncbi.nlm.nih.gov/pubmed/36969545
http://dx.doi.org/10.2147/CMAR.S398539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038009/
https://www.ncbi.nlm.nih.gov/pubmed/36969545
http://dx.doi.org/10.2147/CMAR.S398539

Ejemplares similares